Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print

Promotions & Moves

Related Searches:

Filter by:

HollisterStier Laboratories
May 13, 2008
Rick Lapointe has been appointed president of HollisterStier Laboratories’ Contract Manufacturing unit, responsible for overseeing business development, manufactur¬ing, engineering, validation and process development functions. Mr. Lapointe…   Read More »
MedImmune
May 7, 2008
MedImmune it has enhanced its leadership team to guide the company's expanded product pipeline and core scientific research. Jacqueline Hall has been appointed global vice president, product development team leadership; Lorin Roskos, Ph.D. has been a…   Read More »
Kendle
May 7, 2008
Patricia Williams has been appointed to the position of vice  president, commercial operations, Kendle. In this newly created  position, Ms. Williams will provide leadership for global contract  execution and negotiation with the…   Read More »
Eisai Corp.
May 5, 2008
Eisai Corp. of North America has appointed Cynthia Schwalm president of Eisai Inc. In her new role, Ms. Schwalm will have full operating responsibility for leading Eisai Inc., the U.S. commercial operation of Eisai Co., Ltd.     Ms.…   Read More »
GlaxoSmithKline
May 1, 2008
GlaxoSmithKline has made several changes to its corporate executive management team. The appointments will take effect on May 22 when Andrew Witty officially assumes the role of chief executive officer.     Mr. Witty remarked, "…   Read More »
Wyeth
May 1, 2008
Robert R. Ruffolo, Jr., Ph.D. will retire as president, Wyeth Research and senior vice president, Wyeth, later this year. He will be succeeded by Mikael Dohlsten, M.D., Ph.D.     Dr. Ruffolo joined Wyeth in November 2000 and has bee…   Read More »
PAREXEL
April 30, 2008
Imogene Grimes, Ph.D. has been appointed to vice president of Data Sciences Strategic Services, PAREXEL International Corp. In this role, Dr. Grimes will contribute to the continued expansion of the company's data science services, including data man…   Read More »
Alfacell Corp.
April 28, 2008
Kuslima Shogen, chief executive officer and scientific founder of Alfacell Corp., will retire from the company on or before March 31, 2009. The company also announced that the royalty agreement between Ms. Shogen and Alfacell has been terminated. &n…   Read More »
USP
April 18, 2008
Joseph G. Stowell of the Chao Center for Industrial Pharmacy and Contract  Manufacturing has been appointed to serve on the U.S. Pharmacopeia (USP) Expert Committee for monograph development: ophthalmology, oncology, and dermatology.  &nb…   Read More »
Alcan Packaging
April 16, 2008
Michael Rubenstein, currently president of Alcan Packaging's Global Pharmaceutical Packaging business, has been appointed to the newly created position of chief growth and innovation officer. In this new role, Mr. Rubenstein will lead a team dedicate…   Read More »
Kendle
April 15, 2008
Simon S. Higginbotham has been promoted to the role of president at Kendle. Chris Bergen, who previously had served as president and chief operating officer, will continue to serve in the latter role. Mr. Higginbotham will provide global leadership f…   Read More »
Novartis
April 11, 2008
Novartis AG has promoted two senior U.S. executives to head its U.S. drugs unit and overall U.S. operations. Ludwig Hantson, head of Novartis' specialty medicines unit in the U.S., has been promoted to chief executive of Novartis Pharmaceuticals Corp…   Read More »
PharmEng International
April 10, 2008
PharmEng International, Inc. has appointed John Durham as corporate vice president, business development for Keata Pharma, Inc., a wholly owned subsidiary of PharmEng. Keata has pharmaceutical contract manufacturing facilities in Arnprior, ON and new…   Read More »
Stiefel Laboratories
April 8, 2008
Gavin Corcoran, M.D., FACP, has been appointed to the newly created position of chief scientific officer at Stiefel Laboratories. The position was created to "reinforce the already critical role played by the R&D organization and the unity b…   Read More »
PPD, Inc.
April 4, 2008
Paul Covington, M.D. is retiring as executive vice president of development and chief medical officer of PPD, Inc., effective June 30. He will serve as a special project adviser through January 2009 to assist with selected projects and the transition…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: